Annual Retained Earnings
$279.79 M
-$146.40 M-34.35%
December 31, 2023
Summary
- As of February 7, 2025, ABCL annual retained earnings is $279.79 million, with the most recent change of -$146.40 million (-34.35%) on December 31, 2023.
- During the last 3 years, ABCL annual retained earnings has risen by +$165.59 million (+144.99%).
- ABCL annual retained earnings is now -34.35% below its all-time high of $426.19 million, reached on December 31, 2022.
Performance
ABCL Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
$151.14 M
-$51.11 M-25.27%
September 30, 2024
Summary
- As of February 7, 2025, ABCL quarterly retained earnings is $151.14 million, with the most recent change of -$51.11 million (-25.27%) on September 30, 2024.
- Over the past year, ABCL quarterly retained earnings has dropped by -$51.11 million (-25.27%).
- ABCL quarterly retained earnings is now -66.86% below its all-time high of $456.08 million, reached on September 30, 2022.
Performance
ABCL Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
ABCL Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -34.4% | -25.3% |
| 3 y3 years | +145.0% | -27.2% |
| 5 y5 years | +10000.0% | +3304.8% |
ABCL Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -34.4% | +4.5% | -66.9% | at low |
| 5 y | 5-year | -34.4% | +6032.7% | -66.9% | +3304.8% |
| alltime | all time | -34.4% | +6032.7% | -66.9% | +3304.8% |
AbCellera Biologics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $151.14 M(-25.3%) |
| Jun 2024 | - | $202.25 M(-15.4%) |
| Mar 2024 | - | $239.18 M(-14.5%) |
| Dec 2023 | $279.79 M(-34.4%) | $279.79 M(-14.4%) |
| Sep 2023 | - | $326.94 M(-8.0%) |
| Jun 2023 | - | $355.55 M(-7.9%) |
| Mar 2023 | - | $386.07 M(-9.4%) |
| Dec 2022 | $426.19 M | $426.19 M(-6.6%) |
| Sep 2022 | - | $456.08 M(+6.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $429.45 M(-1.6%) |
| Mar 2022 | - | $436.24 M(+63.0%) |
| Dec 2021 | $267.67 M(+134.4%) | $267.67 M(+28.9%) |
| Sep 2021 | - | $207.72 M(-9.3%) |
| Jun 2021 | - | $229.10 M(-1.0%) |
| Mar 2021 | - | $231.42 M(+102.6%) |
| Dec 2020 | $114.20 M(-2521.6%) | $114.20 M(-4182.7%) |
| Sep 2020 | - | -$2.80 M(-40.7%) |
| Dec 2019 | -$4.72 M(+88.3%) | -$4.72 M |
| Dec 2018 | -$2.50 M | - |
FAQ
- What is AbCellera Biologics annual retained earnings?
- What is the all time high annual retained earnings for AbCellera Biologics?
- What is AbCellera Biologics annual retained earnings year-on-year change?
- What is AbCellera Biologics quarterly retained earnings?
- What is the all time high quarterly retained earnings for AbCellera Biologics?
- What is AbCellera Biologics quarterly retained earnings year-on-year change?
What is AbCellera Biologics annual retained earnings?
The current annual retained earnings of ABCL is $279.79 M
What is the all time high annual retained earnings for AbCellera Biologics?
AbCellera Biologics all-time high annual retained earnings is $426.19 M
What is AbCellera Biologics annual retained earnings year-on-year change?
Over the past year, ABCL annual retained earnings has changed by -$146.40 M (-34.35%)
What is AbCellera Biologics quarterly retained earnings?
The current quarterly retained earnings of ABCL is $151.14 M
What is the all time high quarterly retained earnings for AbCellera Biologics?
AbCellera Biologics all-time high quarterly retained earnings is $456.08 M
What is AbCellera Biologics quarterly retained earnings year-on-year change?
Over the past year, ABCL quarterly retained earnings has changed by -$51.11 M (-25.27%)